Health Atlas
Menu
Evidence-led reference

Prevention & care

Glaucoma: optic-nerve damage, eye pressure, types, testing, and treatment goals

9 sources · Latest source check 2026-10-20 UTC
On this page

Glaucoma is a group of conditions that damage the optic nerve, the connection carrying visual signals toward the brain. Some forms develop slowly and initially cause no obvious symptoms. Others can cause an acute emergency. Feeling that vision is normal does not rule out early disease.[6]

The drainage angle and other causes matter

The drainage angle and other causes matter
Type or termSelected explanation
Open-angle glaucomaThe drainage angle remains open, but fluid drainage may be impaired.[3]
Normal-tension glaucomaAn open-angle form occurring despite pressure in the usual range.[2]
Angle-closure glaucomaThe iris obstructs the drainage angle; this may occur acutely or more slowly.[2]
Secondary glaucomaAnother condition or injury contributes; inflammation, pigment or abnormal blood vessels are examples.[2]
Congenital or pediatric glaucomaGlaucoma affecting babies or children, including developmental drainage problems.[2]

Fluid inside the eye is different from the surface tear film

Fluid circulates through the front chamber inside the eye and drains near the junction of the iris and cornea. Impaired outflow can increase internal pressure. This is different from tears lubricating the outer surface; a watery eye does not tell someone what their internal pressure is.[3]

High pressure increases glaucoma risk, but risk and existing nerve damage are different findings. Ocular hypertension describes elevated pressure; it is not automatically proof of glaucoma. The pressure a particular nerve tolerates varies, so a single number should not be used as a universal self-diagnosis.[3]

Slow loss and sudden symptoms need different responses

Many people do not notice early changes. Peripheral, or side, vision can be affected gradually. Waiting for a symptom before seeking an indicated eye examination can therefore miss disease; recommended examination frequency depends on risk and the clinical setting.[1]

Sudden intense eye pain, a red eye, blurred vision, halos, nausea or vomiting can signal an acute eye emergency and need immediate assessment. Similar symptoms can have other causes. They should not be dismissed because a previous appointment or pressure reading was reassuring.[6]

Pressure measurement is part of a wider assessment

Eye examination checks for glaucoma and other problems. Visual-field testing measures areas of vision, including peripheral vision. Pressure measurements, nerve assessment and visual function address related but different questions; one test result alone is not the entire disease history.[1]

The NHS describes specialist assessment after suspected glaucoma and follow-up to check treatment. Changes over time help clinicians judge control. A person can need ongoing monitoring even while symptoms are absent or a recent pressure reading has improved.[6]

Different approaches can share the goal of reducing pressure

Drops, laser treatment and surgery are options selected according to type and circumstances. The aim is to slow further damage and preserve vision. The need to use prescribed drops and attend follow-up remains part of care; symptom improvement is not the only measure of success.[6]

Laser trabeculoplasty is used for selected open-angle glaucoma to help fluid drain. Other laser procedures address other forms. Treatment can cause temporary soreness or irritation, may not work for everyone, and may not remove the need for drops or later treatment.[4]

Surgery changes drainage; it does not regenerate the optic nerve

Trabeculectomy creates an additional drainage opening. Implant surgery uses a drainage tube or shunt. Minimally invasive glaucoma surgery, or MIGS, covers several procedures with different suitability. These are categories rather than one interchangeable operation or a claim that every newer procedure is best.[5]

Surgery can reduce pressure but cannot undo established vision loss. Risks can include cataract, corneal problems, pressure becoming too low or further vision loss. Drainage benefit can lessen over time, which is another reason for follow-up rather than treating an operation as a permanent all-purpose cure.[5]

Laser can be an initial option in a selected adult pathway

The National Institute for Health and Care Excellence (NICE) adult England guidance offers selective laser trabeculoplasty, or SLT, for newly diagnosed chronic open-angle glaucoma that is not advanced, with specified exceptions. It is not a rule for every glaucoma type. The discussion includes side effects, time to effect and possible repeat treatment. Drops remain an option when laser is unsuitable, declined or insufficient. Ask how the proposed pathway fits the diagnosed subtype and stage; a general first-line recommendation does not choose treatment for an individual.[7]

Evidence & uncertainty

Lowering eye pressure can help protect remaining vision, but established damage is not restored by ordinary glaucoma treatment. Pressure is important without being the whole diagnosis: some people with high pressure do not develop glaucoma, and glaucoma can occur at a pressure within the usual range.[3]

Selected-source overview · Independent review pending

Published questions

Does high eye pressure automatically mean glaucoma?

Selected-source overview · Independent review pending. Read the evidence context.

Elevated pressure increases risk, but it is not automatically proof of optic-nerve damage.[3]

Evidence behind this answer
  • Glaucoma and Eye Pressure

    agency anatomy explanation · 2024
    Selected relevant official page passages inspected · Internal fluid drainage, variable nerve tolerance and high pressure versus glaucoma

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can glaucoma occur with normal-range eye pressure?

Selected-source overview · Independent review pending. Read the evidence context.

Normal-tension glaucoma is one example.[2]

Evidence behind this answer
  • Types of Glaucoma

    agency patient explanation · 2024
    Selected relevant official page passages inspected · Normal tension, acute/chronic angle closure, secondary and pediatric examples

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can glaucoma be present before obvious symptoms?

Selected-source overview · Independent review pending. Read the evidence context.

Some forms develop gradually and initially have no noticeable symptoms.[6]

Evidence behind this answer
  • Glaucoma

    agency patient explanation · 2025
    Selected relevant official page passages inspected · Definition, acute warning symptoms, specialist assessment and follow-up

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Is every angle-closure glaucoma attack sudden?

Selected-source overview · Independent review pending. Read the evidence context.

Angle closure can also develop more slowly. Acute symptoms still require emergency assessment.[2]

Evidence behind this answer
  • Types of Glaucoma

    agency patient explanation · 2024
    Selected relevant official page passages inspected · Normal tension, acute/chronic angle closure, secondary and pediatric examples

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does glaucoma surgery restore vision already lost to nerve damage?

Selected-source overview · Independent review pending. Read the evidence context.

Its aim is to protect remaining vision by helping control pressure.[5]

Evidence behind this answer
  • Glaucoma Surgery

    agency procedure explanation · 2026
    Selected relevant official page passages inspected · Drainage procedures, limits, recurrence and possible harms

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Does glaucoma laser treatment always eliminate the need for eye drops?

Selected-source overview · Independent review pending. Read the evidence context.

Further drops or procedures may still be needed.[4]

Evidence behind this answer
  • Laser Treatment for Glaucoma

    agency procedure explanation · Date not stated
    Selected relevant official page passages inspected · Selected trabeculoplasty, drainage goal, discomfort and continued treatment

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Can babies or children have glaucoma?

Selected-source overview · Independent review pending. Read the evidence context.

Pediatric glaucoma includes congenital forms and other childhood presentations.[2]

Evidence behind this answer
  • Types of Glaucoma

    agency patient explanation · 2024
    Selected relevant official page passages inspected · Normal tension, acute/chronic angle closure, secondary and pediatric examples

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

Must everyone try glaucoma eye drops before laser treatment?

Selected-source overview · Independent review pending. Read the evidence context.

No. The UK National Institute for Health and Care Excellence offers selective laser trabeculoplasty as an initial option for selected adults with newly diagnosed nonadvanced chronic open-angle glaucoma. Other types, advanced disease, contraindications and preferences need their own assessment; this is not a universal laser-first rule.[7]

Evidence behind this answer
  • Glaucoma: diagnosis and management (NG81)

    clinical guideline · 2022-01-26
    original guideline selected sections read via fallback. Treatment section 1.4 including initial OHT/nonadvanced COAG choices, exceptions, repeat laser and technique/adherence checks. No independent full evidence appraisal or qualified review completed. · Treatment section 1.4 including initial OHT/nonadvanced COAG choices, exceptions, repeat laser and technique/adherence checks.

This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.

LiGHT compared initial treatment pathways over six years

LiGHT followed initially untreated open-angle glaucoma or ocular hypertension randomly assigned to laser-first or drops-first care. At six years, 524 people completed follow-up, about 83% of those entering the extension. Three reported quality-of-life measures did not clearly differ; one glaucoma-symptom scale favored laser-first. Clinical control favored laser-first on selected outcomes. After year three, switching to laser was allowed in the drops arm and further laser was allowed in the laser arm. This compares continuing pathways, not one laser session against lifelong unchanged drops.[8]

The 2025 correction clarifies the surgical outcome as incisional glaucoma surgery, with corrected counts of 33 drops-first versus 16 laser-first eyes. The correction and underlying report are one work, not independent evidence.[8][9]

References

  1. Glaucoma

    Agency patient explanation

    National Eye Institute · Content/publication date: 2026
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Early symptoms, peripheral vision and visual-field examination

    Updated 19 August 2026. Limited use alongside the existing eye-health article; no universal examination interval or claim that one pressure reading excludes disease.

  2. Types of Glaucoma

    Agency patient explanation

    National Eye Institute · Content/publication date: 2024
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Normal tension, acute/chronic angle closure, secondary and pediatric examples

    Updated 5 December 2024. Tracking parameter removed from the same work. Acute and chronic angle closure are distinguished; no US prevalence ranking is generalised globally.

  3. Glaucoma and Eye Pressure

    Agency anatomy explanation

    National Eye Institute · Content/publication date: 2024
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Internal fluid drainage, variable nerve tolerance and high pressure versus glaucoma

    Updated 5 December 2024. No self-diagnostic pressure threshold; internal fluid is distinguished editorially from external tears.

  4. Laser Treatment for Glaucoma

    Agency procedure explanation

    National Eye Institute · Content/publication date: not stated
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Selected trabeculoplasty, drainage goal, discomfort and continued treatment

    Selected procedure explanation. No head-to-head ranking, universal recovery deadline or guarantee that drops can be stopped.

  5. Glaucoma Surgery

    Agency procedure explanation

    National Eye Institute · Content/publication date: 2026
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Drainage procedures, limits, recurrence and possible harms

    Updated 20 August 2026. MIGS procedures are not treated as a uniformly superior class; no independent comparison or numerical surgical success claim.

  6. Glaucoma

    Agency patient explanation

    NHS · Content/publication date: 2025
    Accessed: 2026-10-07 UTC · Selected relevant official page passages inspected
    Cited sections: Definition, acute warning symptoms, specialist assessment and follow-up

    Reviewed 13 June 2025; separate video review date in April 2026. UK pathway examples are not universal global screening policy.

  7. Glaucoma: diagnosis and management (NG81)

    Clinical guideline

    National Institute for Health and Care Excellence · Content/publication date: 2022-01-26
    Accessed: 2026-10-20 UTC · original guideline selected sections read via fallback. Treatment section 1.4 including initial OHT/nonadvanced COAG choices, exceptions, repeat laser and technique/adherence checks. No independent full evidence appraisal or qualified review completed.
    Cited sections: Treatment section 1.4 including initial OHT/nonadvanced COAG choices, exceptions, repeat laser and technique/adherence checks.

    Adult England pathway; subtype and individual assessment matter.

  8. LiGHT trial: six-year results

    Randomized trial extended followup

    Gazzard G and LiGHT Trial Study Group · Content/publication date: 2023
    Accessed: 2026-10-20 UTC · original indexed abstract read. Original indexed abstract including population, primary endpoint, attrition and crossover; repository abstract inspected. Full main publication not independently appraised. No independent full evidence appraisal or qualified review completed.
    Cited sections: Original indexed abstract including population, primary endpoint, attrition and crossover; repository abstract inspected. Full main publication not independently appraised.

    Six-year pathway comparison; correction shares this work allowance.

  9. Corrigendum to LiGHT six-year results

    Published correction

    Ophthalmology; correction to Gazzard and colleagues · Content/publication date: 2025
    Accessed: 2026-10-20 UTC · original correction read via fallback. Complete correction body and corrected Table 4; initial AAO fallback returned page chrome only and was not substantive access. No independent full evidence appraisal or qualified review completed.
    Cited sections: Complete correction body and corrected Table 4; initial AAO fallback returned page chrome only and was not substantive access.

    Corrected surgical category and counts, not an independent trial.

Scope & review

Population
General glaucoma literacy, including distinct acute and pediatric contexts
Exposure or intervention
Optic nerve, pressure, selected types, examination and care
Comparison
Risk versus diagnosis; internal fluid versus tears; preserving versus restoring vision
Outcomes
Progression, remaining vision, daily function and treatment harms
Timeframe
Often gradual progression with separate acute emergencies and ongoing monitoring
Jurisdiction
US NEI and UK NHS explanations; screening and procedure access vary

Selected-source educational explanation. Official guidance, original study findings and editorial interpretation are distinguished. No exhaustive search, independent systematic synthesis or qualified medical review has been completed.

Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.

Revision history
  • 2026-10-08 UTC: Added a sourced explanation in a bounded ten-article batch; qualified review remains pending.
  • 2026-10-20 UTC: Added bounded depth26 explanation after complete target and relevant neighboring-body audit; old section, FAQ and source objects retained exactly. Original-source access and cumulative current/pending work accounting recorded; qualified review remains pending.

What this article still leaves open

  • Independent comparative evidence for initial laser, drop classes, surgery and individual MIGS procedures.
  • Detailed diagnostic testing, ocular-hypertension risk estimates and type-specific care pathways.
Suggest a correction

Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.

Explore the topic map

Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.